Skip to main content
Top
Published in: Medical Oncology 1/2009

01-03-2009 | Original Paper

Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients

Authors: Nuray Buyukberber, Süleyman Buyukberber, Alper Sevinc, Celalettin Camci

Published in: Medical Oncology | Issue 1/2009

Login to get access

Abstract

Assay of cytokines and C reactive protein (CRP) in different periods of febrile neutropenia may be helpful for early defining the risk in severe infections. We determined serum interleukin-6 (IL-6), interleukin-8 (IL-8), soluble interleukin-2 receptor (sIL-2R), tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and CRP in 22 previously untreated patients with various malignancies. Samples were obtained in four different clinical periods of febrile neutropenia; prior to chemotherapy, afebrile neutropenic period after chemotherapy, febrile neutropenic period, and recovery period. When compared to sex-and age-matched group of healthy subjects, IL-6, IL-8, sIL-2R, and CRP levels were found to be elevated in all periods. The highest levels were encountered in the febrile neutropenic period. For predictivity purposes, the afebrile neutropenic period was the most important period. Serum sIL-2R, IL-6, IL-8 and CRP levels were elevated in this period. IL-8 levels showed the most stable elevation through different stages of febrile neutropenia. Serum IL-8 levels were found to have the most reliable and stable elevation in different clinical stages of febrile neutropenia. Nevertheless, IL-8 is not able to discriminate among risk groups and cannot be used as a predictive factor.
Literature
1.
go back to reference Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol. 1994;12:107–14.PubMed Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol. 1994;12:107–14.PubMed
4.
go back to reference Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer. 1999;86:126–34. doi :10.1002/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1.PubMedCrossRef Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer. 1999;86:126–34. doi :10.1002/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1.PubMedCrossRef
7.
go back to reference Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol. 1992;10:316–22.PubMed Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol. 1992;10:316–22.PubMed
8.
go back to reference Klaassen RJ, Goodman TR, Pham B, Doyle JJ. ‘Low-risk’ prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012–9.PubMed Klaassen RJ, Goodman TR, Pham B, Doyle JJ. ‘Low-risk’ prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012–9.PubMed
10.
go back to reference Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038–51.PubMed Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038–51.PubMed
12.
go back to reference Lehrnbecher T, Venzon D, de Haas M, Chanock S, Kuhl J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29:414–9. doi:10.1086/520224.PubMedCrossRef Lehrnbecher T, Venzon D, de Haas M, Chanock S, Kuhl J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29:414–9. doi:10.​1086/​520224.PubMedCrossRef
14.
go back to reference Herrmann JL, Blanchard H, Brunengo P, Lagrange PH. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values. Infection. 1994;22:309–15. doi:10.1007/BF01715533.PubMedCrossRef Herrmann JL, Blanchard H, Brunengo P, Lagrange PH. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values. Infection. 1994;22:309–15. doi:10.​1007/​BF01715533.PubMedCrossRef
15.
go back to reference Engervall P, Granstrom M, Andersson B, Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol. 1995;54:226–34.PubMed Engervall P, Granstrom M, Andersson B, Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol. 1995;54:226–34.PubMed
17.
go back to reference Pechumer H, Wilhelm M, Ziegler-Heitbrock HW. Interleukin-6 levels in febrile children during maximal aplasia after bone marrow transplantation are similar to those in children with normal hematopoiesis. Ann Hematol. 1995;70:309–12. doi:10.1007/BF01696617.PubMedCrossRef Pechumer H, Wilhelm M, Ziegler-Heitbrock HW. Interleukin-6 levels in febrile children during maximal aplasia after bone marrow transplantation are similar to those in children with normal hematopoiesis. Ann Hematol. 1995;70:309–12. doi:10.​1007/​BF01696617.PubMedCrossRef
19.
20.
go back to reference Stryjewski GR, Nylen ES, Bell MJ, Snider RH, Becker KL, Wu A, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med. 2005;6:129–35. doi:10.1097/01.PCC.0000149317.15274.48.PubMedCrossRef Stryjewski GR, Nylen ES, Bell MJ, Snider RH, Becker KL, Wu A, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med. 2005;6:129–35. doi:10.​1097/​01.​PCC.​0000149317.​15274.​48.PubMedCrossRef
21.
go back to reference Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection. 1998;26:213–21.PubMedCrossRef Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection. 1998;26:213–21.PubMedCrossRef
22.
go back to reference Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol. 2000;111:1093–102. doi:10.1046/j.1365-2141.2000.02458.x.PubMedCrossRef Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol. 2000;111:1093–102. doi:10.​1046/​j.​1365-2141.​2000.​02458.​x.PubMedCrossRef
23.
go back to reference Kern WV, Heiss M, Steinbach G. Prediction of Gram-negative bacteremia in patients with cancer and febrile neutropenia by means of ınterleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy. Clin Infect Dis. 2001;32:832–5. doi:10.1086/319207.PubMedCrossRef Kern WV, Heiss M, Steinbach G. Prediction of Gram-negative bacteremia in patients with cancer and febrile neutropenia by means of ınterleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy. Clin Infect Dis. 2001;32:832–5. doi:10.​1086/​319207.PubMedCrossRef
25.
go back to reference Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis. 1992;165:886–90.PubMed Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis. 1992;165:886–90.PubMed
26.
go back to reference Engel A, Kern WV, Mürdter G, Kern P. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumour necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection. 1994;2:160–3. doi:10.1007/BF01716695.CrossRef Engel A, Kern WV, Mürdter G, Kern P. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumour necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection. 1994;2:160–3. doi:10.​1007/​BF01716695.CrossRef
27.
go back to reference von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539–44. doi:10.1007/s10096-004-1156-y.CrossRef von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539–44. doi:10.​1007/​s10096-004-1156-y.CrossRef
29.
go back to reference Katz JA, Mustafa MM, Bash RO, Cash JV, Buchanan GR. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis. 1992;11:708–12.CrossRef Katz JA, Mustafa MM, Bash RO, Cash JV, Buchanan GR. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis. 1992;11:708–12.CrossRef
30.
go back to reference Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis. 1995;21:114–21.PubMed Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis. 1995;21:114–21.PubMed
31.
go back to reference Lindemann A, Tamm I, Tanodi K, Mertelsmann R. Interleukin-8 serum levels for early detection of infections episodes in neutropenic patients. J Infect Dis. 1995;172:610–3.PubMed Lindemann A, Tamm I, Tanodi K, Mertelsmann R. Interleukin-8 serum levels for early detection of infections episodes in neutropenic patients. J Infect Dis. 1995;172:610–3.PubMed
32.
go back to reference Schonbohn H, Schuler M, Kolbe K, Peschel C, Huber C, Bemb W, et al. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-R A during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol. 1995;71:161–8. doi:10.1007/BF01910312.PubMedCrossRef Schonbohn H, Schuler M, Kolbe K, Peschel C, Huber C, Bemb W, et al. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-R A during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol. 1995;71:161–8. doi:10.​1007/​BF01910312.PubMedCrossRef
35.
go back to reference Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson LO, et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis. 2004;36:365–71. doi:10.1080/00365540410020217.PubMedCrossRef Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson LO, et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis. 2004;36:365–71. doi:10.​1080/​0036554041002021​7.PubMedCrossRef
36.
go back to reference Erten N, Genc S, Besisik SK, Saka B, Karan MA, Tascioglu C. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J Chin Med Assoc. 2004;67:217–21.PubMed Erten N, Genc S, Besisik SK, Saka B, Karan MA, Tascioglu C. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J Chin Med Assoc. 2004;67:217–21.PubMed
37.
38.
go back to reference Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–51. doi:10.1086/339215.PubMedCrossRef Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–51. doi:10.​1086/​339215.PubMedCrossRef
Metadata
Title
Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients
Authors
Nuray Buyukberber
Süleyman Buyukberber
Alper Sevinc
Celalettin Camci
Publication date
01-03-2009
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 1/2009
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9081-z

Other articles of this Issue 1/2009

Medical Oncology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.